Volume 16 - Issue 6 - June 2019
FDA Panel
Vascular Disease Management June 2019
VDM talks with Prakash Krishnan, MD, FACC, Director, Endovascular Services, Cardiac Catheterization Laboratory, Associate Professor of Medicine, Cardiology, The Mount Sinai Hospital, New York, New York. Dr. Krishan was the co-national primary investigator of the ILLUMENATE study.
VDM talks with Prakash Krishnan, MD, FACC, Director, Endovascular Services Cardiac Catheterization Laboratory, Associate Professor of Medicine, Cardiology, The Mount Sinai Hospital, New York, New York. Dr. Krishan was the co-national primary investig…
Case Report
VASCULAR DISEASE MANAGEMENT 2019;16(6):E72-E75.
Gi-Ann Acosta, BS, and Richard Neville, MD
Neville and Acosta demonstrate the use of an autologous vein for arterial reconstruction. The case is unique in that rather than opting for amputation in a patient with CLI not amenable to open bypass surgery or endovascular therapy, they devised a n…
FDA Panel
Vascular Disease Management June 2019
VDM talks with Robert E. Beasley, MD, FSIR, FSCAI, Director, Vascular/Interventional Radiology Lab and Evanescence Vein Center, Mount Sinai Medical Center, Miami Beach, Florida.
VDM talks with Robert E. Beasley, MD, FSIR, FSCAI, Director, Vascular/Interventional Radiology Lab and Evanescence Vein Center,
Mount Sinai Medical Center, Miami Beach, Florida.
FDA Panel
Vascular Disease Management June 2019
VDM talks with Konstantinos Katsanos, MSc, MD, PhD, EBIR, Assistant Professor, Interventional Radiology, School of Medicine, Patras University Hospital, Patras, Greece.
VDM talks with Konstantinos Katsanos, MSc, MD, PhD, EBIR, Assistant Professor, Interventional Radiology, School of Medicine, Patras University Hospital, Patras, Greece.
FDA Panel
Vascular Disease Management June 2019
Steve Henao, MD, FACS, FACC, Vascular Surgery and Vascular Interventional Radiology, New Mexico Heart Institute, Albuquerque, New Mexico
Steve Henao, MD, FACS, FACC, Vascular Surgery and Vascular Interventional Radiology, New Mexico Heart Institute, Albuquerque, New Mexico
FDA Panel
Vascular Disease Management June 2019
Richard R. Heuser, FACC, FACP, FESC, MSCAI, Chief of Cardiology, St. Luke's Medical Center; Professor of Medicine, University of Arizona School of Medicine; Phoenix Heart Center, Phoenix, Arizona
Richard R. Heuser, FACC, FACP, FESC, MSCAI, Chief of Cardiology, St. Luke's Medical Center; Professor of Medicine, University of Arizona School of Medicine; Phoenix Heart Center, Phoenix, Arizona
FDA Panel
Vascular Disease Management June 2019
VDM talks with Frank J. Veith, MD, Professor of Surgery, New York University-Langone Medical Center and The Cleveland Clinic Lerner College of Medicine; The William J. von Liebig Chair in Vascular Surgery; Cleveland, Ohio and New York, New York. Dr. Veith is Founder and Chairman of VEITHsymposium, now in its 46th year.
Learn more at VEITHsymposium.org.
VDM talks with Frank J. Veith, MD, Professor of Surgery, New York University-Langone Medical Center and The Cleveland Clinic Lerner College of Medicine; The William J. von Liebig Chair in Vascular Surgery; Cleveland, Ohio and New York, New York. Dr.…
FDA Panel
Vascular Disease Management June 2019
Jihad A. Mustapha, MD, FACC, FSCAI, Advanced Cardiac & Vascular Centers for Amputation Prevention, Grand Rapids, Michigan
Jihad A. Mustapha, MD, FACC, FSCAI, Advanced Cardiac & Vascular Centers for Amputation Prevention, Grand Rapids, Michigan
FDA Panel
VDM talks with Daniel Clair, MD, Chair of Surgery, Palmetto Health/USC Medical Group, Columbia, South Carolina.
Dr. Daniel Clair can be contacted at daniel.clair@uscmed.sc.edu.
VDM talks with Daniel Clair, MD, Chair of Surgery, Palmetto Health/USC Medical Group, Columbia, South Carolina, regarding the FDA panel meeting that took place June 19th-20th, and his thoughts on drug-coated balloon use.
Case Report
VASCULAR DISEASE MANAGEMENT 2019;16(4):E82-E84.
Gabriel T. Brandner, BS1; George L. Adams, MD2, MHS, FACC; Rachel C. Hurst, BS1; Mason Nagel, BS3
1Duke University of Durham, North Carolina
2Rex Hospital in Raleigh, North Carolina
3North Carolina State University of Raleigh, North Carolina
In the case herein, procedural success — defined by stenosis reduction and distal reperfusion of bilateral stumps — was dependent upon gaining arterial access through exotic techniques and crossing the CTOs.
Back to Top